Skip to main content

Back to guidelines homepage

Stem Cell Therapies in Obstetrics and Gynaecology (Scientific Impact Paper No. 38)

Published: 22/05/2013

This is the first edition of this Scientific Impact Paper.

This paper recognises that reproductive and fetal tissues are sources of stem cells and targets for regenerative medicine.

Such treatments in gynaecology are still in the preclinical and clinical phases, and the field of obstetrics has primarily focused on these interventions for fetal therapies. This paper discusses the possibilities, progress and problems of regenerative medicine to the genital tract and stem cell treatment of genetic diseases.

The paper also acknowledges the ethical issues and unknown risks and limitations that have arisen within this area.